EUVIMEDEUVIMED entdecken
Crossref

A Stearyl‐Peptide Based Versatile Strategy to Design Enzyme‐Responsive Liposomes for Targeted Drug Delivery

Shruti Raghunathan, Norman Luc, Dante Disharoon, Sonali Rohiwal, Keren Hu, Rahul Darbhakul, Jenny Lian, Hanyang Wang, Rohini Sekar, Bipin Chakravarthy Paruchuri, Elizabeth Wakelin, Ujjal Didar Singh Sekhon und 1 weitere

Advanced Healthcare Materials · 17.11.2026

DOI: 10.1002/adhm.71990 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 17.11.2026. Verfasst von Shruti Raghunathan und 12 weiteren Autor:innen. Die Arbeit nennt 100 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liposomes are a prominent class of drug delivery nanoparticles. For currently approved liposomal therapeutics, drug is released predominantly via diffusion which has spatio‐temporal kinetic and bioavailability challenges, especially in a dynamic environment. Next‐generation liposome designs focus on stimuli‐triggered enhancement of drug release. One exciting approach here is liposomes that can be site‐specifically destabilized by disease‐associated enzymes. Feasibility of this has been demonstrated with certain phospholipases or metalloproteases, but a versatile strategy for designing liposomes triggerable by any disease‐specific enzyme remains lacking. We report a unique liposome design using enzyme‐cleavable stearyl‐peptide conjugates. Stearylamine has been explored for cationic liposomes in gene delivery, but the cationic charge poses significant cytotoxicity. We demonstrate that conjugating enzyme‐cleavable peptides to stearylamine and assembly of stearyl‐peptide conjugates within liposomes mitigates the cationic charge and significantly enhances biosafety. Surface‐decorating such liposomes with target‐specific ligands enables their active target‐anchorage under flow. Exposure of target‐anchored liposomes to disease‐relevant enzymes renders stearyl‐peptide cleavage and liposome destablization, enhancing drug release. We demonstrate the design versatility utilizing microfluidic models of three different vascular pathologies (hyperfibrinolysis, thrombosis and thromboinflammation) and delivering three corresponding drugs (tranexamic acid, tissue plasminogen activator and deoxyribonulease) triggered by three different enzymes (plasmin, thrombin and neutrophil elastase), respectively.

Zitieren

APA

Raghunathan, S., Luc, N., Disharoon, D., Rohiwal, S., Hu, K., Darbhakul, R., Lian, J., Wang, H., Sekar, R., Paruchuri, B. C., Wakelin, E., Sekhon, U. D. S., & Gupta, A. S. (2026). A Stearyl‐Peptide Based Versatile Strategy to Design Enzyme‐Responsive Liposomes for Targeted Drug Delivery. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71990

Vancouver

Raghunathan S, Luc N, Disharoon D, Rohiwal S, Hu K, Darbhakul R, et al. A Stearyl‐Peptide Based Versatile Strategy to Design Enzyme‐Responsive Liposomes for Targeted Drug Delivery. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71990

BibTeX
@article{Raghunathan2026,
  author = {Raghunathan, Shruti and Luc, Norman and Disharoon, Dante and Rohiwal, Sonali and Hu, Keren and Darbhakul, Rahul and Lian, Jenny and Wang, Hanyang and Sekar, Rohini and Paruchuri, Bipin Chakravarthy and Wakelin, Elizabeth and Sekhon, Ujjal Didar Singh and Gupta, Anirban Sen},
  title = {A Stearyl‐Peptide Based Versatile Strategy to Design Enzyme‐Responsive Liposomes for Targeted Drug Delivery},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.71990}
}
Kostenlos starten →